Insulin legislation looks to cap medication at $35/mo.

As 34 million people in the country battle diabetes, lawmakers are attempting to address insulin costs, which have affected countless Americans who depend on this medication. The Affordable Insulin Now Act would enact drug pricing reform for this medication, capping the monthly out-of-pocket cost of insulin at $35 for people with commercial insurance, group health plans, Medicare, and California's MediCal.